{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:07:33Z","timestamp":1764828453597},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-244x-13-176","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T18:14:20Z","timestamp":1372356860000},"source":"Crossref","is-referenced-by-count":17,"title":["Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Cenk","family":"Tek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Guloksuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod H","family":"Srihari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin L","family":"Reutenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"issue":"1\u20133","key":"1362_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.schres.2010.12.008","volume":"127","author":"VH Phutane","year":"2011","unstructured":"Phutane VH, Tek C, Chwastiak L, Ratliff JC, Ozyuksel B, Woods SW, Srihari VH: Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?. Schizophr Res. 2011, 127 (1\u20133): 257-261.","journal-title":"Schizophr Res"},{"issue":"9690","key":"1362_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0140-6736(09)61072-2","volume":"374","author":"LA Chwastiak","year":"2009","unstructured":"Chwastiak LA, Tek C: The unchanging mortality gap for people with schizophrenia. Lancet. 2009, 374 (9690): 590-592. 10.1016\/S0140-6736(09)61072-2.","journal-title":"Lancet"},{"issue":"1","key":"1362_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.psym.2012.03.001","volume":"54","author":"JC Ratliff","year":"2013","unstructured":"Ratliff JC, Palmese LB, Reutenauer EL, Srihari VH, Tek C: Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness. Psychosomatics. 2013, 54 (1): 67-73. 10.1016\/j.psym.2012.03.001.","journal-title":"Psychosomatics"},{"issue":"15","key":"1362_CR4","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1001\/jama.298.15.1794","volume":"298","author":"JW Newcomer","year":"2007","unstructured":"Newcomer JW, Hennekens CH: Severe mental illness and risk of cardiovascular disease. JAMA. 2007, 298 (15): 1794-1796. 10.1001\/jama.298.15.1794.","journal-title":"JAMA"},{"issue":"11","key":"1362_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1176\/appi.ps.55.11.1250","volume":"55","author":"DR Jones","year":"2004","unstructured":"Jones DR, Macias C, Barreira PJ, Fisher WH, Hargreaves WA, Harding CM: Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv. 2004, 55 (11): 1250-1257. 10.1176\/appi.ps.55.11.1250.","journal-title":"Psychiatr Serv"},{"issue":"12","key":"1362_CR6","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.4088\/JCP.v64n1205","volume":"64","author":"PE Keck","year":"2003","unstructured":"Keck PE, McElroy SL: Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry. 2003, 64 (12): 1426-1435. 10.4088\/JCP.v64n1205.","journal-title":"J Clin Psychiatry"},{"issue":"9690","key":"1362_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"J Tiihonen","year":"2009","unstructured":"Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009, 374 (9690): 620-627. 10.1016\/S0140-6736(09)60742-X.","journal-title":"Lancet"},{"issue":"4","key":"1362_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4088\/JCP.v60n0402","volume":"60","author":"DB Allison","year":"1999","unstructured":"Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, Weiden PJ, Cheskin LJ: The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiat. 1999, 60 (4): 215-220. 10.4088\/JCP.v60n0402.","journal-title":"J Clin Psychiat"},{"issue":"5","key":"1362_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4088\/JCP.v66n0503","volume":"66","author":"KM Saari","year":"2005","unstructured":"Saari KM, Lindeman SM, Viilo KM, Isohanni MK, Jarvelin MR, Lauren LH, Savolainen MJ, Koponen HJ: A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study. J Clin Psychiatry. 2005, 66 (5): 559-563. 10.4088\/JCP.v66n0503.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"1362_CR10","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"DB Allison","year":"1999","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ: Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999, 156 (11): 1686-1696.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1362_CR11","doi-asserted-by":"publisher","first-page":"e04","DOI":"10.4088\/JCP.0207e04","volume":"68","author":"JA Lieberman","year":"2007","unstructured":"Lieberman JA: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. J Clin Psychiatry. 2007, 68 (2): e04-10.4088\/JCP.0207e04.","journal-title":"J Clin Psychiatry"},{"key":"1362_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1192\/bjp.187.6.537","volume":"187","author":"RB Zipursky","year":"2005","unstructured":"Zipursky RB, Gu H, Green AI, Perkins DO, Tohen MF, McEvoy JP, Strakowski SM, Sharma T, Kahn RS, Gur RE, et al: Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. The British journal of psychiatry : the journal of mental science. 2005, 187: 537-543. 10.1192\/bjp.187.6.537.","journal-title":"The British journal of psychiatry : the journal of mental science"},{"issue":"Suppl 7","key":"1362_CR13","first-page":"4","volume":"62","author":"DE Casey","year":"2001","unstructured":"Casey DE, Zorn SH: The pharmacology of weight gain with antipsychotics. J Clin Psychiatry. 2001, 62 (Suppl 7): 4-10.","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"1362_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4088\/JCP.v65n1007","volume":"65","author":"B Arranz","year":"2004","unstructured":"Arranz B, Rosel P, Ramirez N, Duenas R, Fernandez P, Sanchez JM, Navarro MA, San L: Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients. J Clin Psychiatry. 2004, 65 (10): 1335-1342. 10.4088\/JCP.v65n1007.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1362_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/sj.npp.1300027","volume":"28","author":"WK Kroeze","year":"2003","unstructured":"Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL: H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2003, 28 (3): 519-526. 10.1038\/sj.npp.1300027.","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"1362_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/npp.2008.169","volume":"34","author":"OJ Marston","year":"2009","unstructured":"Marston OJ, Heisler LK: Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2009, 34 (1): 252-253. 10.1038\/npp.2008.169.","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"1362_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/7854_2010_89","volume":"6","author":"E Stice","year":"2011","unstructured":"Stice E, Yokum S, Zald D, Dagher A: Dopamine-based reward circuitry responsivity, genetics, and overeating. Curr Top Behav Neurosci. 2011, 6: 81-93.","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"1362_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0149-7634(95)00033-B","volume":"20","author":"KC Berridge","year":"1996","unstructured":"Berridge KC: Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996, 20 (1): 1-25. 10.1016\/0149-7634(95)00033-B.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"1362_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0149-7634(02)00041-6","volume":"26","author":"MR Yeomans","year":"2002","unstructured":"Yeomans MR, Gray RW: Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev. 2002, 26 (6): 713-728. 10.1016\/S0149-7634(02)00041-6.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"1362_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.peptides.2004.01.006","volume":"25","author":"RJ Bodnar","year":"2004","unstructured":"Bodnar RJ: Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides. 2004, 25 (4): 697-725. 10.1016\/j.peptides.2004.01.006.","journal-title":"Peptides"},{"issue":"1","key":"1362_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.physbeh.2004.04.032","volume":"82","author":"AS Levine","year":"2004","unstructured":"Levine AS, Billington CJ: Opioids as agents of reward-related feeding: a consideration of the evidence. Physiol Behav. 2004, 82 (1): 57-61. 10.1016\/j.physbeh.2004.04.032.","journal-title":"Physiol Behav"},{"issue":"1","key":"1362_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","volume":"51","author":"D Cota","year":"2006","unstructured":"Cota D, Tschop MH, Horvath TL, Levine AS: Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res Rev. 2006, 51 (1): 85-107. 10.1016\/j.brainresrev.2005.10.004.","journal-title":"Brain Res Rev"},{"issue":"5","key":"1362_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0031-9384(90)90211-L","volume":"48","author":"D Scavo","year":"1990","unstructured":"Scavo D, Barletta C, Vagiri D, Burla F, Fontana M, Lazzari R: Hyperendorphinemia in obesity is not related to the affective state. Physiol Behav. 1990, 48 (5): 681-683. 10.1016\/0031-9384(90)90211-L.","journal-title":"Physiol Behav"},{"issue":"3","key":"1362_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/appe.1994.1022","volume":"22","author":"JC Melchior","year":"1994","unstructured":"Melchior JC, Rigaud D, Chayvialle JA, Colas-Linhart N, Laforest MD, Petiet A, Comoy E, Apfelbaum M: Palatability of a meal influences release of beta-endorphin, and of potential regulators of food intake in healthy human subjects. Appetite. 1994, 22 (3): 233-244. 10.1006\/appe.1994.1022.","journal-title":"Appetite"},{"issue":"1","key":"1362_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tics.2010.11.001","volume":"15","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, Wang GJ, Baler RD: Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011, 15 (1): 37-46. 10.1016\/j.tics.2010.11.001.","journal-title":"Trends Cogn Sci"},{"issue":"5","key":"1362_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1517\/14728222.6.5.601","volume":"6","author":"GJ Wang","year":"2002","unstructured":"Wang GJ, Volkow ND, Fowler JS: The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets. 2002, 6 (5): 601-609. 10.1517\/14728222.6.5.601.","journal-title":"Expert Opin Ther Targets"},{"issue":"9253","key":"1362_CR27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0140-6736(00)03643-6","volume":"357","author":"GJ Wang","year":"2001","unstructured":"Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS: Brain dopamine and obesity. Lancet. 2001, 357 (9253): 354-357. 10.1016\/S0140-6736(00)03643-6.","journal-title":"Lancet"},{"issue":"7","key":"1362_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.comppsych.2012.02.003","volume":"53","author":"JC Ratliff","year":"2012","unstructured":"Ratliff JC, Palmese LB, Reutenauer EL, Liskov E, Grilo CM, Tek C: The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr Psychiatry. 2012, 53 (7): 1028-1033. 10.1016\/j.comppsych.2012.02.003.","journal-title":"Compr Psychiatry"},{"issue":"3","key":"1362_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0920-9964(02)00212-8","volume":"62","author":"B Kirkpatrick","year":"2003","unstructured":"Kirkpatrick B, Messias EM, Tek C: Substance abuse and the heterogeneity of schizophrenia a population-based study. Schizophr Res. 2003, 62 (3): 293-294. 10.1016\/S0920-9964(02)00212-8.","journal-title":"Schizophr Res"},{"issue":"6","key":"1362_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1055\/s-2001-18034","volume":"34","author":"T Baptista","year":"2001","unstructured":"Baptista T, Lacruz A, Angeles F, Silvera R, de Mendoza S, Mendoza MT, Hernandez L: Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry. 2001, 34 (6): 223-231. 10.1055\/s-2001-18034.","journal-title":"Pharmacopsychiatry"},{"key":"1362_CR31","first-page":"217","volume":"16","author":"SS O'Malley","year":"2003","unstructured":"O'Malley SS, Froehlich JC: Advances in the use of naltrexone: an integration of preclinical and clinical findings. Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism. 2003, 16: 217-245.","journal-title":"Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism"},{"issue":"4","key":"1362_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/clpt.1985.197","volume":"38","author":"RL Atkinson","year":"1985","unstructured":"Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL: Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther. 1985, 38 (4): 419-422. 10.1038\/clpt.1985.197.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1362_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0006-3223(96)00523-9","volume":"41","author":"U Zimmermann","year":"1997","unstructured":"Zimmermann U, Rechlin T, Plaskacewicz GJ, Barocka A, Wildt L, Kaschka WP: Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: an open study. Biol Psychiatry. 1997, 41 (6): 747-749. 10.1016\/S0006-3223(96)00523-9.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1362_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/oby.2010.147","volume":"19","author":"TA Wadden","year":"2011","unstructured":"Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, Perri MG, Pi-Sunyer FX, Rock CL, Erickson JS, et al: Weight loss with naltrexone SR\/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity. 2011, 19 (1): 110-120. 10.1038\/oby.2010.147.","journal-title":"Obesity"},{"issue":"12","key":"1362_CR35","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1210\/jc.2009-1350","volume":"94","author":"FL Greenway","year":"2009","unstructured":"Greenway FL, Dunayevich E, Tollefson G, Erickson J, Guttadauria M, Fujioka K, Cowley MA, Group NBS: Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J Clin Endocrinol Metabol. 2009, 94 (12): 4898-4906. 10.1210\/jc.2009-1350.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"1362_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","volume":"52","author":"TP George","year":"2002","unstructured":"George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR: A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry. 2002, 52 (1): 53-61. 10.1016\/S0006-3223(02)01339-2.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"1362_CR37","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/j.1530-0277.1996.tb01142.x","volume":"20","author":"FK Del Boca","year":"1996","unstructured":"Del Boca FK, Kranzler HR, Brown J, Korner PF: Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res. 1996, 20 (8): 1412-1417. 10.1111\/j.1530-0277.1996.tb01142.x.","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"1362_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00870315","volume":"8","author":"PM Dubbert","year":"1985","unstructured":"Dubbert PM, King A, Rapp SR, Brief D, Martin JE, Lake M: Riboflavin as a tracer of medication compliance. J Behav Med. 1985, 8 (3): 287-299. 10.1007\/BF00870315.","journal-title":"J Behav Med"},{"issue":"3","key":"1362_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR: The Brief Psychiatric Scale. Psychol Rep. 1962, 10 (3): 799-812. 10.2466\/pr0.1962.10.3.799.","journal-title":"Psychol Rep"},{"issue":"2","key":"1362_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987, 13 (2): 261-276. 10.1093\/schbul\/13.2.261.","journal-title":"Schizophr Bull"},{"key":"1362_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571. 10.1001\/archpsyc.1961.01710120031004.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"1362_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","volume":"29","author":"AJ Stunkard","year":"1985","unstructured":"Stunkard AJ, Messick S: The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985, 29 (1): 71-83. 10.1016\/0022-3999(85)90010-8.","journal-title":"J Psychosom Res"},{"issue":"8","key":"1362_CR43","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/sj.ijo.0800659","volume":"22","author":"GD Foster","year":"1998","unstructured":"Foster GD, Wadden TA, Swain RM, Stunkard AJ, Platte P, Vogt RA: The Eating Inventory in obese women: clinical correlates and relationship to weight loss. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 1998, 22 (8): 778-785. 10.1038\/sj.ijo.0800659.","journal-title":"International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity"},{"issue":"1","key":"1362_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.appet.2007.05.001","volume":"50","author":"BA Toll","year":"2008","unstructured":"Toll BA, Katulak NA, Williams-Piehota P, O'Malley S: Validation of a scale for the assessment of food cravings among smokers. Appetite. 2008, 50 (1): 25-32. 10.1016\/j.appet.2007.05.001.","journal-title":"Appetite"},{"issue":"12","key":"1362_CR45","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/acr.20644","volume":"63","author":"P Semanik","year":"2011","unstructured":"Semanik P, Lee J, Manheim L, Dipietro L, Dunlop D, Chang RW: Relationship between accelerometer-based measures of physical activity and the Yale Physical Activity Survey in adults with arthritis. Arthritis Care Res. 2011, 63 (12): 1766-1772. 10.1002\/acr.20644.","journal-title":"Arthritis Care Res"},{"issue":"1\u20133","key":"1362_CR46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.schres.2008.04.040","volume":"104","author":"LA Lindamer","year":"2008","unstructured":"Lindamer LA, McKibbin C, Norman GJ, Jordan L, Harrison K, Abeyesinhe S, Patrick K: Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophr Res. 2008, 104 (1\u20133): 294-301.","journal-title":"Schizophr Res"},{"issue":"2","key":"1362_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.nut.2008.08.006","volume":"25","author":"M Skouroliakou","year":"2009","unstructured":"Skouroliakou M, Giannopoulou I, Kostara C, Vasilopoulou M: Comparison of predictive equations for resting metabolic rate in obese psychiatric patients taking olanzapine. Nutrition. 2009, 25 (2): 188-193. 10.1016\/j.nut.2008.08.006.","journal-title":"Nutrition"},{"issue":"7","key":"1362_CR48","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s11136-005-2816-9","volume":"14","author":"M Ritsner","year":"2005","unstructured":"Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J: Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2005, 14 (7): 1693-1703. 10.1007\/s11136-005-2816-9.","journal-title":"Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation"},{"issue":"6","key":"1362_CR49","first-page":"473","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical care. 1992, 30 (6): 473-483.","journal-title":"I. Conceptual framework and item selection. Medical care"},{"issue":"7","key":"1362_CR50","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.eurpsy.2005.05.009","volume":"20","author":"G Reine","year":"2005","unstructured":"Reine G, Simeoni MC, Auquier P, Loundou A, Aghababian V, Lancon C: Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments. Eur Psychiatry. 2005, 20 (7): 510-519. 10.1016\/j.eurpsy.2005.05.009.","journal-title":"Eur Psychiatry"},{"key":"1362_CR51","first-page":"1","volume":"334","author":"O Lingjaerde","year":"1987","unstructured":"Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta psychiatrica Scandinavica Supplementum. 1987, 334: 1-100.","journal-title":"A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta psychiatrica Scandinavica Supplementum"},{"issue":"7","key":"1362_CR52","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","volume":"164","author":"K Posner","year":"2007","unstructured":"Posner K, Oquendo MA, Gould M, Stanley B, Davies M: Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007, 164 (7): 1035-1043. 10.1176\/appi.ajp.164.7.1035.","journal-title":"Am J Psychiatry"},{"key":"1362_CR53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","volume":"22","author":"D Addington","year":"1993","unstructured":"Addington D, Addington J, Maticka-Tyndale E: Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl. 1993, 22: 39-44.","journal-title":"Br J Psychiatry Suppl"},{"issue":"9","key":"1362_CR54","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991, 86 (9): 1119-1127. 10.1111\/j.1360-0443.1991.tb01879.x.","journal-title":"Br J Addict"},{"issue":"2\u20133","key":"1362_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","volume":"68","author":"RS Keefe","year":"2004","unstructured":"Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L: The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004, 68 (2\u20133): 283-297.","journal-title":"Schizophr Res"},{"issue":"2","key":"1362_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/13803390500360539","volume":"28","author":"RS Keefe","year":"2006","unstructured":"Keefe RS, Poe M, Walker TM, Harvey PD: The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol. 2006, 28 (2): 260-269. 10.1080\/13803390500360539.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"1362_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007, 39 (2): 175-191. 10.3758\/BF03193146.","journal-title":"Behav Res Methods"},{"issue":"Suppl 1","key":"1362_CR58","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW: Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005, 19 (Suppl 1): 1-93.","journal-title":"CNS Drugs"},{"issue":"3","key":"1362_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130100711","volume":"155","author":"K Wahlbeck","year":"2001","unstructured":"Wahlbeck K, Tuunainen A, Ahokas A, Leucht S: Dropout rates in randomised antipsychotic drug trials. Psychopharmacology. 2001, 155 (3): 230-233. 10.1007\/s002130100711.","journal-title":"Psychopharmacology"},{"issue":"12","key":"1362_CR60","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.4088\/JCP.v63n1206","volume":"63","author":"DO Perkins","year":"2002","unstructured":"Perkins DO: Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry. 2002, 63 (12): 1121-1128. 10.4088\/JCP.v63n1206.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1362_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/clpt.1989.122","volume":"46","author":"P Rudd","year":"1989","unstructured":"Rudd P, Byyny RL, Zachary V, LoVerde ME, Titus C, Mitchell WD, Marshall G: The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther. 1989, 46 (2): 169-176. 10.1038\/clpt.1989.122.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"1362_CR62","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1176\/ps.2007.58.9.1151","volume":"58","author":"VH Srihari","year":"2007","unstructured":"Srihari VH, Tek C, Chwastiak LA, Woods SW, Steiner JL: Best practices: surveillance and management of diabetes in a CMHC population. Psychiatr Serv. 2007, 58 (9): 1151-1153. 10.1176\/appi.ps.58.9.1151.","journal-title":"Psychiatr Serv"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-176\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T18:08:51Z","timestamp":1688321331000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-176","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,27]]},"article-number":"176"}}